US demand for implantable medical devices will increase 8.3 percent annually through 2014. Gains will be driven by the development of next generation devices based on new technologies and improved materials. Spinal implants, cardiac stents and orthobiologics will be among the fastest growing product categories.
This study analyzes the $33 billion US implantable medical device industry. It presents historical demand data for the years 1999, 2004 and 2009, and forecasts for 2014 and 2019 by procedure, material (e.g., microelectronics, specialty metals, polymers, elastomers) and type (e.g., orthopedic, cardiac, neurological, ophthalmic, breast, drug, urological, cochlear, dermal).
The study also considers market environment factors, details industry structure, evaluates company market share and profiles 36 industry competitors, including Medtronic, Johnson & Johnson and Boston Scientific.